These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


257 related items for PubMed ID: 15950973

  • 1. Synthesis, physicochemical and anticonvulsant properties of N-benzyl and N-aminophenyl derivatives of 2-azaspiro[4.4]nonane and [4.5]decane-1,3-dione. Part I.
    Obniska J, Dzierzawska-Majewska A, Zagorska A, Zajdel P, Karolak-Wojciechowska J.
    Farmaco; 2005; 60(6-7):529-39. PubMed ID: 15950973
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synthesis and anticonvulsant properties of a series of N-substituted 2-aza-spiro[4.5]decane-1,3-diones and 8-phenyl-2-aza-spiro[4.5]decane-1,3-diones.
    Obniska J.
    Acta Pol Pharm; 2004; 61(6):467-72. PubMed ID: 15794340
    [Abstract] [Full Text] [Related]

  • 5. Synthesis, physicochemical and anticonvulsant properties of new N-(pyridine-2-yl) derivatives of 2-azaspiro[4.4]nonane and [4.5]decane-1,3-dione. Part II.
    Kaminski K, Obniska J, Zagorska A, Maciag D.
    Arch Pharm (Weinheim); 2006 May; 339(5):255-61. PubMed ID: 16511896
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, anticonvulsant activity and 5-HT1A, 5-HT2A receptor affinity of new N-[(4-arylpiperazin-1-yl)-alkyl] derivatives of 2-azaspiro[4.4]nonane and [4.5]decane-1,3-dione.
    Obniska J, Kołaczkowski M, Bojarski AJ, Duszyńska B.
    Eur J Med Chem; 2006 Jul; 41(7):874-81. PubMed ID: 16600439
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and preliminary evaluation of anticonvulsant activity of some [4-(benzyloxy) benzoyl]- and [4-(benzyloxy) benzyl] aminoalkanol derivatives.
    Waszkielewicz AM, Cegła M, Marona H.
    Acta Pol Pharm; 2007 Jul; 64(2):147-57. PubMed ID: 17665864
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and anticonvulsant activity of new spirosuccinimides differently substituted at the imide nitrogen atom.
    Obniska J, Kamiński K, Chlebek I.
    Acta Pol Pharm; 2009 Jul; 66(6):663-9. PubMed ID: 20050530
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and anticonvulsant activity of N-3-arylamide substituted 5,5-cyclopropanespirohydantoin derivatives.
    He X, Zhong M, Zhang T, Wu W, Wu Z, Yang J, Xiao Y, Pan Y, Qiu G, Hu X.
    Eur J Med Chem; 2010 Dec; 45(12):5870-7. PubMed ID: 20947222
    [Abstract] [Full Text] [Related]

  • 10. Impact of aromatic substitution on the anticonvulsant activity of new N-(4-arylpiperazin-1-yl)-alkyl-2-azaspiro[4,5]decane-1,3-dione derivatives.
    Obniska J, Kamiński K, Tatarczyńska E.
    Pharmacol Rep; 2006 Dec; 58(2):207-14. PubMed ID: 16702622
    [Abstract] [Full Text] [Related]

  • 11. Synthesis, physicochemical, and anticonvulsant properties of new N-Mannich bases derived from pyrrolidine-2,5-dione and its 3-methyl analog.
    Rybka S, Obniska J, Rapacz A, Filipek B, Kamiński K.
    Arch Pharm (Weinheim); 2014 Oct; 347(10):768-76. PubMed ID: 25139813
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis, and anticonvulsant activity of N-phenylamino derivatives of 3,3-dialkyl-pyrrolidine-2,5-diones and hexahydro-isoindole-1,3-diones.
    Kamiński K, Obniska J.
    Bioorg Med Chem; 2008 May 01; 16(9):4921-31. PubMed ID: 18375131
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, anticonvulsant properties and 5-HT1A/5-HT2A receptor affinity of new N-[(4-arylpiperazin-1-yl)-propyl]-2-aza-spiro[4.4]nonane and [4.5]decane-1,3-dione derivatives.
    Obniska J, Kołaczkowski M, Charakchieva-Minol S, Nedza K, Dybała M, Bojarski AJ.
    Pharmacol Rep; 2005 May 01; 57(3):336-44. PubMed ID: 15985716
    [Abstract] [Full Text] [Related]

  • 14. Design and synthesis of 6-amino-1,4-oxazepane-3,5-dione derivatives as novel broad spectrum anticonvulsants.
    Sharma G, Park JY, Park MS.
    Bioorg Med Chem Lett; 2008 Jun 01; 18(11):3188-91. PubMed ID: 18479918
    [Abstract] [Full Text] [Related]

  • 15. Design, synthesis, and anticonvulsant activity of new N-Mannich bases derived from spirosuccinimides and spirohydantoins.
    Obniska J, Byrtus H, Kamiński K, Pawłowski M, Szczesio M, Karolak-Wojciechowska J.
    Bioorg Med Chem; 2010 Aug 15; 18(16):6134-42. PubMed ID: 20638856
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and anticonvulsant properties of new Mannich bases derived from 3-aryl-pyrrolidine-2,5-diones. Part 1.
    Obniska J, Kopytko M, Zagórska A, Chlebek I, Kamiński K.
    Arch Pharm (Weinheim); 2010 Jun 15; 343(6):333-41. PubMed ID: 20379970
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and anticonvulsant activity of some new hexahydropyrimidine-2,4-dione derivatives.
    Septioglu E, Aytemir MD, Caliş U.
    Arzneimittelforschung; 2005 Jun 15; 55(5):259-64. PubMed ID: 15960424
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and anticonvulsant properties of new N-[(4-arylpiperazin-1-yl)-methyl] derivatives of 3-aryl pyrrolidine-2,5-dione and 2-aza-spiro[4.4]nonane-1,3-dione.
    Obniska J, Zagorska A.
    Farmaco; 2003 Dec 15; 58(12):1227-34. PubMed ID: 14630232
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and potential anticonvulsant activity of new N-3-substituted 5,5-cyclopropanespirohydantoins.
    Zhu Q, Pan Y, Xu Z, Li R, Qiu G, Xu W, Ke X, Wu L, Hu X.
    Eur J Med Chem; 2009 Jan 15; 44(1):296-302. PubMed ID: 18396358
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and anticonvulsant activity of some alkanamide derivatives.
    Tarikogullari AH, Kilic FS, Erol K, Pabuccuoglu V.
    Arzneimittelforschung; 2010 Jan 15; 60(10):593-8. PubMed ID: 21125808
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.